Drs. Adam Adler and Anthony Vella Receive an NIH R21 Grant

Dr. Adam Adler and Dr. Anthony Vella
Congratulations to Dr. Adam Adler and Dr. Anthony Vella for receiving an NIH R21 grant entitled, “Test if antitumor T cells use a putative super-enhancer in the IL1RL2-IL1RL1 intergenic region to form "innate-like" responses to cytokines.”